NEW YORK (Reuters Health) - The radiation that might cure a breast cancer may also raise a woman's risk of having a heart attack or heart disease later in life, according a new study that looked back at the cases of 2,168 women in Sweden and Denmark.

Women with HER2 positive metastatic breast cancer whose cancer grows despite other standard therapies have a new treatment option available next month, now that the Food and Drug Administration approved the EMILIA study’s T-DM1.

NEW YORK (Reuters Health) - More young women are being diagnosed with advanced, metastatic breast cancer than were three decades ago, a new study suggests - although the overall rate of cancers in that group is still small.

A retrospective analysis of 4,554 women treated with taxane-based chemotherapy found that though neuropathy is a common side effect, its presence does not predict better outcomes such as longer overall survival or lower risk of recurrence. Neuropathy is damage to the nervous system that causes pain, numbness, tingling or swelling of the hands or feet.

NEW YORK (Reuters Health) - Women getting fertility treatments can be reassured that in vitro fertilization (IVF) does not increase their risk of breast and gynecological cancers, according to a new study of Israeli women.

CANBERRA (Reuters) - An Australian court ruled on Friday that two technology companies could hold a patent on genetic material related to cancer, in a case similar to one before the U.S. Supreme Court that has implications for gene-based medicine worldwide.

A study using the Oncotype DX test showed a relationship between Recurrence Score and chances of breast cancer recurrence and survival in women with estrogen receptor-positive breast cancer that traveled to the lymph nodes in and around the armpit (axillary lymph nodes) who were treated with hormonal therapy and chemotherapy.